Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dicing up T-ALL.

Jon C Aster1

  • 1BRIGHAM AND WOMEN'S HOSPITAL.

Blood
|August 22, 2015
PubMed
Summary
This summary is machine-generated.

Researchers discovered a new signaling pathway involving miR-21 and the tumor suppressor Pdcd4. This pathway is crucial for the development of T-cell acute lymphoblastic leukemia (T-ALL) induced by Notch signaling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CCL19<sup>+</sup> fibroblasts define a proliferative niche in chronic lymphocytic leukemia.

bioRxiv : the preprint server for biology·2026
Same author

A multi-adjuvant personal neoantigen vaccine generates potent immunity in melanoma.

Cell·2025
Same author

Single-cell and clonal analysis of AL amyloidosis plasma cells and their bone marrow microenvironment.

Blood·2025
Same author

Molecular mechanism of PP2A/B55α phosphatase inhibition by IER5.

Cell chemical biology·2025
Same author

Integrative cytogenetic and molecular studies unmask "chromosomal mimicry" in hematologic malignancies.

Blood advances·2025
Same author

A neoantigen vaccine generates antitumour immunity in renal cell carcinoma.

Nature·2025
Same journal

Decentralized Clinical Trials in Hematology: the Promise and the Peril.

Blood·2026
Same journal

How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

Blood·2026
Same journal

The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

Blood·2026
Same journal

Precision Transfusion Medicine in the Omics Era.

Blood·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
See all related articles

Area of Science:

  • Molecular Biology
  • Oncology
  • Hematology

Background:

  • T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer.
  • The Notch signaling pathway plays a critical role in T-ALL pathogenesis.
  • MicroRNAs (miRNAs) are increasingly recognized as key regulators in cancer development.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying Notch-mediated T-ALL.
  • To identify novel signaling pathways involved in T-ALL.
  • To investigate the role of miR-21 and Pdcd4 in T-ALL development.

Main Methods:

  • The study likely involved molecular biology techniques such as gene expression analysis, Western blotting, and miRNA profiling.
  • In vivo and in vitro models of T-ALL were probably used to assess the functional significance of the identified pathway.

Related Experiment Videos

  • Genetic manipulation (e.g., knockdown or overexpression) of miR-21 and Pdcd4 was likely employed.

    • Main Results:

    • A novel signaling axis involving miR-21 and the tumor suppressor Pdcd4 was identified.
    • This axis was found to be essential for Notch-mediated induction of T-ALL.
    • miR-21 likely targets Pdcd4, regulating its expression and function in T-ALL development.

    Conclusions:

    • The miR-21/Pdcd4 signaling axis represents a critical component of Notch-driven T-ALL.
    • Targeting this pathway may offer a novel therapeutic strategy for T-cell acute lymphoblastic leukemia.
    • Further research into miRNA regulation in T-ALL is warranted.